Diagnostic usefulness of CD23 and FMC-7 antigen expression patterns in B-cell lymphoma classification

American Journal of Clinical Pathology

Volumn 115, Issue 2, 2001, Pages 258-265

  Garcia, D P ^a   Rooney, M T ^a   Ahmad, E ^a   Davis, B H ^a  

^a Maine Medical Center Research Institute   (United States)

Author keywords

Flow cytometry; Immunophenotype; Leukemia; Lymphoproliferative disorder; Monoclonal gammopathy; Phenotype

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD23 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; DIAGNOSTIC VALUE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ALGORITHMS; ANTIGENS, CD5; ANTIGENS, NEOPLASM; BIOPSY; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPH NODES; LYMPHOMA, B-CELL; RECEPTORS, IGE;

EID: 0035122543     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/VWTK-XYT5-D0DK-06HQ     Document Type: Article

References (27)

1. Hematopathology: Integration of morphologic features and biologic markers for diagnosis
2. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: A progress report
3. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Medical indications
4. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation
5. CD23 antigen regulation and signaling in chronic lymphocytic leukemia
6. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody
7. Diagnostic utility of CD23 and FMC-7 co-expression in the subclassification of B-cell lymphoproliferative disorders
8. The International Lymphoma Study Group classification of non-Hodgkin's lymphoma: Pathologic features from a large multicenter study
9. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma
10. The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms: An update
11. Distinction between small lymphocytic and mantle cell lymphoma by reactivity for CD23
12. Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases
13. The antigen of mature human B cells detected by the monoclonal antibody FMC7: Studies on the nature of the antigen and modulation of its expression
14. Maturation of human B lymphocytes: Studies with a panel of monoclonal antibodies against membrane antigens
15. Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC-7
16. FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20
17. Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance
18. Prolymphocytoid transformation of CLL: A clinical and immunological study of 22 cases
19. Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy
20. Clinical utility of flow cytometry in the chronic lymphoid leukemias
21. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia
22. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
23. Mantle cell lymphoma
24. Mantle cell lymphoma: Natural history defined in serially biopsied population over a 20-year period
25. Patterns of survival in mantle cell lymphoma
26. A cytological analysis of FMC-7 positive leukaemias
27. Heterogeneity of CLL: High CD23 antigen and alphaIFN receptor expression are features of favorable disease and of cell activation